Precision medicine is part of 5 focus areas of the Challenges in IBD Research 2024
research document, which also includes preclinical human IBD mechanisms, environmental …

Introduction Artificial intelligence (AI) is expected to impact all facets of inflammatory bowel
disease (IBD) management, including disease assessment, treatment decisions, discovery …

Despite huge advances in understanding the molecular basis of IBD, clinical management
has continued to rely on a “trial and error” approach. In addition, a therapeutic ceiling has …

IBD is a complex multifactorial inflammatory disease of the gut driven by extrinsic and
intrinsic factors, including host genetics, the immune system, environmental factors and the …

Inflammatory bowel diseases [IBD] are a heterogeneous spectrum with two extreme
phenotypes, Crohn's disease [CD] and ulcerative colitis [UC], which both represent …

Key studies published in 2021 demonstrated mechanisms that drive macrophage–fibroblast
pathogenicity in Crohn's disease, developed multi-omics profiles to predict response to …

The surge of artificial intelligence (AI) in medicine stands on a lengthy, and frequently
reticent, buildout. AI is an all-encompassing term for techniques that enable the software to …

Abstract Background and Objectives In spite of rapid growth of artificial intelligence (AI) in
digestive endoscopy in lesion detection and characterization, the role of AI in inflammatory …

Inflammatory bowel diseases, namely ulcerative colitis and Crohn's disease, are chronic and
relapsing conditions that pose a growing burden on healthcare systems worldwide. Because …

Background and aims Artificial intelligence (AI) technology is being evaluated for its
potential to improve colonoscopic assessment of inflammatory bowel disease (IBD) …